Skip to main content
. 2024 Mar 22;13(3):465–474. doi: 10.21037/tlcr-23-802

Figure 2.

Figure 2

Kaplan-Meier curves of PFS (A) and TTCST (B) according to systemic treatment after subdividing to OprogD patients only. PFS, progression-free survival; TTCST, time to change of systemic treatment; OprogD, oligoprogressive disease.